- -

9 - 12




- ( MMR) 2
9-12

1

MMR

1
MMR 9-12
2553
MMR 9 - 12

Vendor Managed Inventory (VMI) 2553

MMR

MMR 9-12

1.

MMR
Jeryl Lynn
9-12

9-12

: MMR

1 9-12
MMR
1
Urabe
2. MMR 9-12

2.1



Priorix
GlaxoSmithKline


(Live attenuated vaccine) 3
2.1.1 Schwarz
2.1.2 RIT 4385
Jeryl Lynn
2.1.3 Wistar RA 27/3
2.2

(Lyophilyzed vaccine) 1

1 0.5 .
2.3

(subcutaneous)

2.4

42 12,000
PriorixTM

(
10)

(
1

10)

(
0.1
1)

38 .

37.5 .

39.5 .

39 .

(
0.01
0.1)

Priorix TM

* Transverse
myelitis anaphylaxis
Guillain Barre Syndrome Erythema
multiforme Kawassaki syndrome
* 1 10

( 1 1,000 2,000
1 6,000 )






Priorix TM
2.5

-

neomycin (systemic)




neomycin (contact
dermatitis)
-



3

-




primary secondary immunodeficiency
MMR

HIV

HIV
-

2.6
2.6

-



-




-

(anaphylactic reaction)

-

chick embryo cell

anaphylactic, anaphylactoid

anaphylaxis

-




2.7

3
(seronegative) 98.0
96.1 99.3

2.8

-

2-8 .
6

8
-

3.
MMR

18
061